MedTrace Logo

Potentially Inappropriate Prescription Associated to Multimorbidity

NCT02830425 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 740

Last updated 2020-04-09

No results posted yet for this study

Summary

A prospective multicenter cohort study in 5 hospitals in Spain will be initiated in 2016.

Objectives:

1. To estimate and describe patterns of multimorbidity and polypharmacy in patients over 64 admitted for a chronic disease exacerbation.
2. To analyze the potentially inappropriate prescribing (PPI) drugs according to STOPP / START (SS) criteria.
3. To evaluate the relationship between multimorbidity and PPI and adverse medication (RAM) preventable reaction.

The cohort will include 800 patients \>64 years admitted in internal medicine and / or geriatric department of 5 hospitals of the National Health Service. Application of the SS criteria (released in 2015) on admission and at discharge, and collection of demographic and clinical variables including comorbidities, baseline chronic medication, geriatric syndromes, functional capacity and RAM. Descriptive analysis and bivariate parametric or nonparametric tests will be applied to analyze relationship between morbidity, polypharmacy, SS criteria and RAM. Intraobserver agreement will be assessed for SS criteria. Multiple regression techniques will be applied, where the dependent variable will be the PPI or the RAM.

Conditions

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Fondo de Investigacion Sanitaria

    collaborator OTHER

  • Hospital del Mar

    collaborator OTHER

  • Hospital de Galdakao

    collaborator OTHER

  • Consorci Hospitalari de Vic

    collaborator OTHER

  • Hospital Universitario de Canarias

    collaborator OTHER

  • Corporacion Parc Tauli

    lead OTHER

Principal Investigators

  • Marisa Baré, MD, MPH, PhD · Corporacio Parc Taulí

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2019-07-31
Completion
2019-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02830425 on ClinicalTrials.gov